Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells

被引:68
作者
Del Poeta, M
Chen, SF
Von Hoff, D
Dykstra, CC
Wani, MC
Manikumar, G
Heitman, J
Wall, ME
Perfect, JR
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA
[6] Res Triangle Inst, Dept Chem & Life Sci, Durham, NC USA
[7] Univ Ancona, Osped Umberto 1, Inst Infect Dis & Publ Hlth, I-60121 Ancona, Italy
[8] Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA
[9] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA
关键词
D O I
10.1128/AAC.43.12.2862
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of a series of camptothecin and nitidine derivatives that might interact with topoisomerase I were compared against yeast and cancer cell lines. Our findings reveal that structural modifications to camptothecin derivatives have profound effects on the topoisomerase I-drug poison complex in cells. Although the water-soluble anticancer agents topotecan and irinotecan are less active than the original structure, camptothecin, other derivatives or analogs with substitutions that increase compound solubility have also increased antifungal activities. In fact, a water-soluble prodrug appears to penetrate into the cell and release its active form; the resulting effect in complex with Cryptococcus neoformans topoisomerase I is a fungicidal response and also potent antitumor activity. Some of the compounds that are not toxic to wild-type yeast cells are extremely toxic to the yeast cells when the C. neoformans topoisomerase I target is overexpressed. With the known antifungal mechanism of a camptothecin-topoisomerase I complex as a cellular poison, these findings indicate that drug entry may be extremely important for antifungal activity. Nitidine chloride exhibits antifungal activity against yeast cells through a mechanism(s) other than topoisomerase I and appears to be less active than camptothecin analogs against tumor cells. Finally, some camptothecin analogs exhibit synergistic antifungal activity against yeast cells in combination with amphotericin B in vitro. Our results suggest that camptothecin and/or nitidine derivatives can exhibit potent antifungal activity and that the activities of camptothecin derivatives with existing antifungal drugs may be synergistic against pathogenic fungi. These new compounds, which exhibit potent antitumor activities, will likely require further structural changes to find more selective activity against fungal versus mammalian cells to hold promise as a new class of antifungal agents.
引用
收藏
页码:2862 / 2868
页数:7
相关论文
共 35 条
[1]  
[Anonymous], UNPUB
[2]   CORRELATION OF IN-VITRO FLUCONAZOLE RESISTANCE OF CANDIDA ISOLATES IN RELATION TO THERAPY AND SYMPTOMS OF INDIVIDUALS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
CAMERON, ML ;
SCHELL, WA ;
BRUCH, S ;
BARTLETT, JA ;
WASKIN, HA ;
PERFECT, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2449-2453
[3]  
Del Poeta M, 1999, GENETICS, V152, P167
[4]   In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazoles [J].
Del Poeta, M ;
Schell, WA ;
Dykstra, CC ;
Jones, SK ;
Tidwell, RR ;
Kumar, A ;
Boykin, DW ;
Perfect, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2503-2510
[5]  
ENG WK, 1988, MOL PHARMACOL, V34, P755
[6]   FLUCONAZOLE RESISTANT CANDIDA IN AIDS [J].
FOX, R ;
NEAL, KR ;
LEEN, CLS ;
ELLIS, ME ;
MANDAL, BK .
JOURNAL OF INFECTION, 1991, 22 (02) :201-204
[7]   THE YEAST GENE ERG6 IS REQUIRED FOR NORMAL MEMBRANE-FUNCTION BUT IS NOT ESSENTIAL FOR BIOSYNTHESIS OF THE CELL-CYCLE-SPARKING STEROL [J].
GABER, RF ;
COPPLE, DM ;
KENNEDY, BK ;
VIDAL, M ;
BARD, M .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (08) :3447-3456
[8]  
Gatto B, 1996, CANCER RES, V56, P2795
[9]   DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].
GIOVANELLA, BC ;
STEHLIN, JS ;
WALL, ME ;
WANI, MC ;
NICHOLAS, AW ;
LIU, LF ;
SILBER, R ;
POTMESIL, M .
SCIENCE, 1989, 246 (4933) :1046-1048
[10]  
GOLDMAN GH, 1997, BIOCHEMISTRY-US, V36, P6494